Delivery Order SPE2DB20D3101-SPE2DB25FRKV2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,009.52 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate release formulation) in quantities of 100 units. The award, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, carries a firm fixed price and represents a competitively awarded, non-set-aside contract. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $1,926.55 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units). This firm fixed price contract, which is not set-aside, represents a single delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100, with a contract ceiling value of $3,248.74. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units) with a ceiling value of $1,038.82. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and has an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tacrolimus 5 mg capsules (immediate release) in quantities of 100 units. The contract, valued at $67,741.38, was competitively awarded on July 18, 2025, with an ultimate completion date of July 21, 2025. This delivery order employs firm fixed pricing and carries no set-aside designation. AmerisourceBergen will perform the work at its corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100 units, with a ceiling value of $4,545.64. This firm fixed price contract was awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a non-competitive set-aside delivery order. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $3,512.26 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1mg in quantities of 100 units. The contract, awarded on August 7, 2025, with an ultimate completion date of September 4, 2025, utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,309.12 on August 13, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100 units. This is a firm fixed price contract with no set-aside designation, awarded competitively through the Defense Logistics Agency's Medical Supply Chain. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 100 units of 5 mg Tacrolimus capsules. The $1,903.26 contract has a period of performance through March 22, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and is the sole awardee of a $999,999,999.00 indefinite delivery contract from DLA to deliver pharmaceuticals...
- The Defense Logistics Agency (DLA) awarded a $1,169.28 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,566,256,795 Tacrolimus 1 mg capsules to support military treatment facilities and federal healthcare programs. This contract is a task order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a broad range of...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRKV2Delivery Order
The Defense Logistics Agency awarded a $6,951.06 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100, with an ultimate completion date of May 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, supplying medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Tacrolimus, an immunosuppressant medication, represents the type of specialized pharmaceutical product within the company's extensive contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 5/20/25 |